Fri. 1 Oct 2021, 11:49am ETBenzinga
In: News, Health Care, FDA, General
  • The FDA has granted Emergency Use Authorization (EUA) to Laboratory Corp of America Holdings's (NYSE:LH) combined home collection kit to detect COVID-19 and influenza A/B simultaneously in individuals as young as 2 years of age. 
  • The kit will be available at no upfront cost to those who meet clinical guidelines.
  • Starting in early October, adults 18 and over, as well as parents and guardians of children 2-17 years of age, can request the combined collection kit online through Pixel by Labcorp. 
  • The home collection kit uses the Roche Holdings AG's (OTC:RHHBY) Cobas SARS-CoV-2 & influenza A/B Test on the Cobas 6800/8800 Systems. 
  • Related content: Benzinga's Full FDA Calendar.
  • Price Action: LH stock is down 0.44% at $280.21 during the market session on the last check Friday.